An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
Public ClinicalTrials.gov record NCT03147742. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
Study identification
- NCT ID
- NCT03147742
- Recruitment status
- Approved For Marketing
- Study type
- Expanded access
- Phase
- Not listed
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Ruxolitinib Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 6, 2022
United States locations
- U.S. sites
- 33
- U.S. states
- 22
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Phoenix | Arizona | 85054 | — |
| Cancer Transplant Institute at HonorHealth | Scottsdale | Arizona | 85258 | — |
| City of Hope Medical Center | Duarte | California | 91010 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | — |
| Nicklaus Children's Hospital | Miami | Florida | 33155 | — |
| Blood & Marrow Transplant Center | Orlando | Florida | 32804 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| University of Illinois Chicago | Chicago | Illinois | 60612 | — |
| Indiana Blood and Marrow Transplantation | Indianapolis | Indiana | 46237 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02214 | — |
| University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109-5271 | — |
| Spectrum Health | Grand Rapids | Michigan | 49503 | — |
| Mayo Clinic Minnesota | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Rutgers Cancer Institute | New Brunswick | New Jersey | 08903 | — |
| New Mexico Cancer Center | Albuquerque | New Mexico | 87109 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Gettysburg Cancer Center | Gettysburg | Pennsylvania | 17325 | — |
| Allegheny Health Network Cancer Institute | Pittsburgh | Pennsylvania | 15224 | — |
| Greenville Health System Cancer Institute | Greenville | South Carolina | 29615 | — |
| Avera Research Institute | Sioux Falls | South Dakota | 57105 | — |
| Texas Oncology | Dallas | Texas | 75246 | — |
| Houston Methodist | Houston | Texas | 77030 | — |
| Methodist Hospital | San Antonio | Texas | 78229 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109-1024 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03147742, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 6, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03147742 live on ClinicalTrials.gov.